BHST (BioHarvest Sciences Inc.) Rega marang bathi mangsa ngarep
The price evolution of BioHarvest Sciences (BHST) helps assess the P/E multiple dynamics, which currently stands at 0.00. The business relies on plant cell cultivation methods to create superfoods, earning its status as a reliable technological pioneer. Its environmental development vector is based on minimizing water and arable land costs through the use of modern bioreactors.
Ringkesan rincian data analitis BioHarvest Sciences Inc (BHST)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal BioHarvest Sciences|BHST - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas BioHarvest Sciences|BHST - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku BioHarvest Sciences, Inc.|BHST - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan BioHarvest Sciences|Likuiditas cepet bioharvest.com
- rincian asil keuangan lan kelipatan valuasi:
BHST - Penghasilan resik perusahaan|Proyeksi bathi mangsa ngarep BioHarvest Sciences|BHST - Nilai perusahaan marang bathi resik|Pangali Forward P/E BioHarvest|BHST - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan BioHarvest Sciences, Inc.|BHST - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan BioHarvest Sciences|BHST - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan bioharvest.com|BHST - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep BioHarvest Sciences
- statistik dodolan lan pendapatan perusahaan:
Pambiji fundamental:BioHarvest Sciences Inc.
The forward P/E determines the market value of an asset relative to expected net income, serving as a gauge for investment expectations. This metric compares the current share price with projected earnings to assess the degree to which a security is overbought. By analyzing the forward P/E of a company, an investor gains a real-time assessment of the risk-reward dynamics. For BioHarvest Sciences (BHST), this calculation reflects the efficiency of the transition to cellular bio-growth. Resource optimization within bioreactors directly impacts future margins and the final coefficient.
Perusahaan pesaing
Prakiraan rega marang bathi HLN (Haleon)|KVUE (Kenvue Inc) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Verona Pharma Corp VRNA|Jyong Bio (MENS) - Rasio prakiraan rega marang bathi|LGND: Prakiraan rega marang bathi|amneal.com - Rasio kapitalisasi marang bathi mangsa ngarep|PRGO: Pangali Forward P/E|Alvotech S.A. - Pangali mangsa ngarep rega marang bathi|LQDA (Liquidia Technologies) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Galapagos Corp GLPG|Rega marang bathi mangsa ngarep ANI Pharmaceuticals (ANIP)|MNKD (mannkindcorp.com) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E AMPH (Amphastar Pharmaceuticals, Inc.)|Pacira Pharmaceuticals - Rega marang bathi mangsa ngarep|ARS Pharma - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Theravance Corp TBPH|Aquestive Therapeutics (AQST) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi scPharmaceuticals (SCPH)|TECX (Tectonic Therapeutic Inc.) - Pangali Forward P/E|TNXP: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E SXTC|Pangali Forward P/E eupraxiapharma.com (EPRX)|Rega marang bathi mangsa ngarep eXoZymes Inc EXOZ|Pangali mangsa ngarep rega marang bathi ORMP|ENTX: Prakiraan rega marang bathi|HYFT: Rega marang bathi mangsa ngarep|ABVC: Pangali Forward P/E|Rasio prakiraan rega marang bathi Cumberland Corp (CPIX)|Rega marang bathi mangsa ngarep Quantum BioPharma Ltd|fibrogen.com (FGEN) - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi TELO (Telomir Pharmaceuticals, Inc.)|Rasio kapitalisasi marang bathi mangsa ngarep RANI|Synergy CHC - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi RLYB|LEXX - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi pulmatrix.com PULM|PTHL: Pangali Forward P/E|Prakiraan rega marang bathi Aptorum Group|LYRA (Lyra Therapeutics, Inc) - Pangali Forward P/E|Impact BioMedical, Inc. (IBO) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E TNFA|YCBD - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep PainReform PRFX|CYTO: Rasio rega marang bathi mangsa ngarep|Lipella - Pangali Forward P/E|OptiNose Corp (OPTN) - Prakiraan rega marang bathi|PIRS: Pangali Forward P/E|Rasio prakiraan rega marang bathi procapsgroup.com (PROC)|Rega marang bathi mangsa ngarep Petros Pharmaceuticals, Inc.|Qilian International Holding Group (QLI) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E SLRN|Rega marang bathi mangsa ngarep TFFP (TFF Pharmaceuticals, Inc)
